ReviewStem cells translational medicine2016

Concise Review: Markers for Assessing Human Stem Cell-Derived Implants as β-Cell Replacement in Type 1 Diabetes.

Daniel Pipeleers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.